Coordinatore | ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
Nazionalità Coordinatore | Netherlands [NL] |
Totale costo | 3˙060˙467 € |
EC contributo | 3˙060˙467 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-2012-ITN |
Funding Scheme | MC-ITN |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-11-01 - 2016-10-31 |
# | ||||
---|---|---|---|---|
1 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | coordinator | 954˙835.35 |
2 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 583˙313.28 |
3 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 298˙256.64 |
4 |
GLAXOSMITHKLINE VACCINES SRL
Organization address
address: Via Fiorentina 1 contact info |
IT (SIENA) | participant | 254˙037.96 |
5 |
VALNEVA AUSTRIA GMBH
Organization address
address: CAMPUS VIENNA BIOCENTER 3 contact info |
AT (WIEN) | participant | 253˙401.72 |
6 |
VIB
Organization address
address: Rijvisschestraat 120 contact info |
BE (ZWIJNAARDE - GENT) | participant | 243˙540.00 |
7 |
HADASSAH MEDICAL ORGANIZATION
Organization address
address: n/a contact info |
IL (JERUSALEM) | participant | 237˙813.84 |
8 |
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Organization address
address: Hofgartenstrasse 8 contact info |
DE (MUENCHEN) | participant | 235˙268.88 |
9 |
Intercell AG
Organization address
address: Campus Vienna Biocenter 3 contact info |
AT (Vienna) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Vaccines are the most cost-effective health interventions available (WHO). The impact of vaccination on the health of the world’s population cannot be overstressed. Vaccinolgy is the multidisciplinary discipline of developing vaccine interventions it combines knowledge from basic sciences, medical sciences, public health and social sciences. Ideally a vaccinologists would be able to have a general overview of all disciplines involved but at the same time be able to zoom in on it’s own discipline. There is hardly any formal training to become a vaccinologist in the world and none such training exists at a PhD level in Europe. The need for a program to train vaccinologists is apparent and recognised . The vaccine industry is a largely European based industry. Investing in the future of this industry by training the next generation vaccinologists will boost European’s economy will provide high quality employment and will sustain European’s competitiveness. Clearly there are public health and economic reasons to invest in a training program training the European vaccinologists of the future.'